Status of work in May
AOTMiT begins work on the Ministry of Health’s orders in May:
- Enhertu (trastuzumab deruxtecan) in the treatment of patients with cancer of the esophagus, gastroesophageal junction, and stomach
- Trodelvy (sacituzumab govitecan) in the treatment of breast cancer patients
- Acarizax (dermatophagoides pteronyssinus, dermatophagoides farina) for the treatment of moderate to severe allergic rhinitis caused by house dust
- Abecma (idecabtagene vicleucel) in the treatment of patients with plasma cell myeloma
The listed orders are available on the AOTMiT Public Information Bulletin.